Giovanni Lo Re

Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi et al. · Journal of Clinical Oncology · 2006 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giampiero Gasparini et al. · Journal of Clinical Oncology · 2009 · 168 citations

Medicine, Oncology, Pharmacology +17

Extrapulmonary small cell carcinoma: A single-institution experience and review of the literature

Giovanni Lo Re, Vincenzo Canzonieri, Andrea Veronesi et al. · Annals of Oncology · 1994 · 103 citations · Full text

Medicine, Oncology, Pathology +8

5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes.

Vittorina Zagonel, Giovanni Lo Re, Giuseppe Marotta et al. · PubMed · 1993 · 92 citations

Medicine, Hematology, Pharmacology +8

Clinical validity of a <scp><i>DPYD</i></scp>‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

Giuseppe Toffoli, Luciana Giodini, Angela Buonadonna et al. · International Journal of Cancer · 2015 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17